Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Pilot Study of L-dopa Treatment in Patients With a Neurodevelopmental Disorder Related to a Pathogenic Variant of the CTNNB1 Gene

NCT07614126 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT07614126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07614126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Pilot Study of L-dopa Treatment in Patients With a Neurodevelopmental Disorder Related to a Pathogenic Variant of the CTNNB1 Gene
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Recruiting
Start date
April 8, 2026
Completion date
May 31, 2027
Enrollment
7 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ctnnb1, l-dopa